应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
ACLX ARCELLX, INC.
交易中 07-17 15:28:22 EDT
71.22
+0.52
+0.73%
最高
71.53
最低
69.96
成交量
35.85万
今开
70.75
昨收
70.70
日振幅
2.22%
总市值
39.24亿
流通市值
23.31亿
总股本
5,511万
成交额
2,543万
换手率
1.10%
流通股本
3,273万
市净率
9.41
ROE
-35.56%
每股收益
-3.00
52周最高
107.37
52周最低
47.86
市盈率
-23.76
股息
0.00
股息收益率
0.00
ROA
-16.69%
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Arcellx(ACLX.US)获花旗首次覆盖,给予买入评级, 目标价110.00美元。
金融界 · 06-17
Arcellx(ACLX.US)获花旗首次覆盖,给予买入评级, 目标价110.00美元。
Arcellx, Inc.盘中异动 大幅拉升5.15%
市场透视 · 05-21
Arcellx, Inc.盘中异动 大幅拉升5.15%
Arcellx, Inc.2025财年第一财季实现净利润-62.27百万美元,同比减少764.86%
市场透视 · 05-17
Arcellx, Inc.2025财年第一财季实现净利润-62.27百万美元,同比减少764.86%
Arcellx, Inc.盘中异动 快速上涨5.60%报61.51美元
市场透视 · 05-14
Arcellx, Inc.盘中异动 快速上涨5.60%报61.51美元
Arcellx, Inc.盘中异动 早盘大幅上涨5.77%
市场透视 · 05-12
Arcellx, Inc.盘中异动 早盘大幅上涨5.77%
Scotiabank:维持Arcellx(ACLX.US)评级,由跑赢大盘调整至跑赢大盘评级, 目标价由133.00美元调整至93.00美元。
金融界 · 05-09
Scotiabank:维持Arcellx(ACLX.US)评级,由跑赢大盘调整至跑赢大盘评级, 目标价由133.00美元调整至93.00美元。
Arcellx(ACLX.US):2025年Q1财报实现营收812.9万美元,前值为3925.6万美元,预期值为1951万美元;每股收益为-1.13美元,前值为-0.14美元,预期值为-0.74美元。
金融界 · 05-08
Arcellx(ACLX.US):2025年Q1财报实现营收812.9万美元,前值为3925.6万美元,预期值为1951万美元;每股收益为-1.13美元,前值为-0.14美元,预期值为-0.74美元。
Arcellx, Inc.盘中异动 急速下挫5.01%
市场透视 · 05-06
Arcellx, Inc.盘中异动 急速下挫5.01%
Arcellx, Inc.盘中异动 股价大涨5.99%报66.90美元
市场透视 · 04-23
Arcellx, Inc.盘中异动 股价大涨5.99%报66.90美元
Arcellx, Inc.2024财年实现净利润-1.07亿美元,同比减少51.37%
市场透视 · 03-07
Arcellx, Inc.2024财年实现净利润-1.07亿美元,同比减少51.37%
Arcellx, Inc.盘中异动 临近收盘急速上涨5.01%报68.92美元
市场透视 · 03-05
Arcellx, Inc.盘中异动 临近收盘急速上涨5.01%报68.92美元
Arcellx(ACLX.US):2024年Q4财报实现营收1526.6万美元,前值为6314.8万美元,预期值为2547万美元;每股收益为-0.87美元,前值为0.42美元,预期值为-0.48美元。
金融界 · 02-27
Arcellx(ACLX.US):2024年Q4财报实现营收1526.6万美元,前值为6314.8万美元,预期值为2547万美元;每股收益为-0.87美元,前值为0.42美元,预期值为-0.48美元。
Arcellx 2024财年GAAP每股收益$(2.00)不及预期$(1.66),销售额$107.936百万低于预期$121.765百万
财报速递 · 02-27
Arcellx 2024财年GAAP每股收益$(2.00)不及预期$(1.66),销售额$107.936百万低于预期$121.765百万
Arcellx, Inc.盘中异动 临近午盘股价大跌5.06%
市场透视 · 02-11
Arcellx, Inc.盘中异动 临近午盘股价大跌5.06%
Arcellx, Inc.盘中异动 急速下跌5.03%
市场透视 · 02-03
Arcellx, Inc.盘中异动 急速下跌5.03%
Arcellx, Inc.盘中异动 大幅上涨5.09%
市场透视 · 01-30
Arcellx, Inc.盘中异动 大幅上涨5.09%
Arcellx, Inc.盘中异动 大幅下跌5.02%
市场透视 · 01-13
Arcellx, Inc.盘中异动 大幅下跌5.02%
Arcellx, Inc.盘中异动 快速下跌5.38%
市场透视 · 01-10
Arcellx, Inc.盘中异动 快速下跌5.38%
Arcellx, Inc.盘中异动 早盘股价大跌5.07%
市场透视 · 01-08
Arcellx, Inc.盘中异动 早盘股价大跌5.07%
Arcellx, Inc.盘中异动 下午盘快速下挫5.07%报75.12美元
市场透视 · 01-06
Arcellx, Inc.盘中异动 下午盘快速下挫5.07%报75.12美元
加载更多
公司概况
公司名称:
ARCELLX, INC.
所属市场:
NASDAQ
上市日期:
2022-02-04
主营业务:
Arcellx, Inc.于2014年12月在特拉华州注册成立。他们是一家临床阶段的生物技术公司,通过为癌症和其他无法治愈的疾病患者开发创新的免疫疗法来重新构想细胞疗法。他们的新型合成结合支架D-Domain旨在克服传统嵌合抗原受体T细胞的局限性。
发行价格:
15.00
{"stockData":{"symbol":"ACLX","market":"US","secType":"STK","nameCN":"ARCELLX, INC.","latestPrice":71.215,"timestamp":1752780499126,"preClose":70.7,"halted":0,"volume":358549,"delay":0,"floatShares":32731061,"shares":55106703,"eps":-2.997189,"marketStatus":"交易中","change":0.515,"latestTime":"07-17 15:28:20 EDT","open":70.75,"high":71.53,"low":69.96,"amount":25425082.48096,"amplitude":0.022207,"askPrice":71.35,"askSize":5,"bidPrice":71.09,"bidSize":573,"shortable":3,"etf":0,"ttmEps":-2.997189,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1752782400000},"marketStatusCode":2,"adr":0,"listingDate":1643950800000,"exchange":"NASDAQ","adjPreClose":70.7,"preHourTrading":{"tag":"盘前","latestPrice":70.6,"preClose":70.7,"latestTime":"08:45 EDT","volume":6,"amount":423.70002,"timestamp":1752756312887},"postHourTrading":{"tag":"盘后","latestPrice":70.7,"preClose":70.7,"latestTime":"18:12 EDT","volume":16304,"amount":1152646.67,"timestamp":1752703977703},"volumeRatio":1.165516,"impliedVol":0.5864,"impliedVolPercentile":0.468},"requestUrl":"/m/hq/s/ACLX","defaultTab":"news","newsList":[{"id":"2544964137","title":"Arcellx(ACLX.US)获花旗首次覆盖,给予买入评级, 目标价110.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2544964137","media":"金融界","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544964137?lang=zh_cn&edition=full","pubTime":"2025-06-17 19:44","pubTimestamp":1750160645,"startTime":"0","endTime":"0","summary":"Arcellx(ACLX.US)获花旗首次覆盖,给予买入评级, 目标价110.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/06/17194451125660.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ACLX"],"gpt_icon":0},{"id":"2537936662","title":"Arcellx, Inc.盘中异动 大幅拉升5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537936662","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537936662?lang=zh_cn&edition=full","pubTime":"2025-05-21 21:33","pubTimestamp":1747834401,"startTime":"0","endTime":"0","summary":"北京时间2025年05月21日21时33分,Arcellx, Inc.股票出现异动,股价大幅拉升5.15%。Arcellx, Inc.股票所在的生物技术行业中,整体涨幅为0.12%。Arcellx, Inc.公司简介:Arcellx Inc是一家临床阶段的生物技术公司,通过开发针对癌症和其他不治之症患者的免疫疗法,重新构思细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250521213321a6e78483&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250521213321a6e78483&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ACLX"],"gpt_icon":0},{"id":"2536358441","title":"Arcellx, Inc.2025财年第一财季实现净利润-62.27百万美元,同比减少764.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536358441","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536358441?lang=zh_cn&edition=full","pubTime":"2025-05-18 00:00","pubTimestamp":1747497637,"startTime":"0","endTime":"0","summary":"5月18日,Arcellx, Inc.公布财报,公告显示公司2025财年第一财季净利润为-62.27百万美元,同比减少764.86%;其中营业收入为8.13百万美元,同比减少79.29%,每股基本收益为-1.13美元。从资产负债表来看,Arcellx, Inc.总负债2.31亿美元,其中短期债务7.36百万美元,资产负债比为2.81,流动比率为4.95。机构评级:截至2025年5月18日,当前有15家机构对Arcellx, Inc.目标价做出预测,其中目标均价为111.53美元,其中最低目标价为93.00美元,最高目标价为134.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250518000256a4821e2a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250518000256a4821e2a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACLX"],"gpt_icon":0},{"id":"2535381020","title":"Arcellx, Inc.盘中异动 快速上涨5.60%报61.51美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535381020","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535381020?lang=zh_cn&edition=full","pubTime":"2025-05-14 21:33","pubTimestamp":1747229619,"startTime":"0","endTime":"0","summary":"北京时间2025年05月14日21时33分,Arcellx, Inc.股票出现异动,股价快速拉升5.60%。截至发稿,该股报61.51美元/股,成交量2.3215万股,换手率0.04%,振幅3.47%。Arcellx, Inc.股票所在的生物技术行业中,整体涨幅为0.17%。Arcellx, Inc.公司简介:Arcellx Inc是一家临床阶段的生物技术公司,通过开发针对癌症和其他不治之症患者的免疫疗法,重新构思细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051421334097598630&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051421334097598630&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ACLX","BK4007","SEPN"],"gpt_icon":0},{"id":"2534275674","title":"Arcellx, Inc.盘中异动 早盘大幅上涨5.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2534275674","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534275674?lang=zh_cn&edition=full","pubTime":"2025-05-12 21:34","pubTimestamp":1747056887,"startTime":"0","endTime":"0","summary":"北京时间2025年05月12日21时34分,Arcellx, Inc.股票出现异动,股价快速拉升5.77%。Arcellx, Inc.股票所在的生物技术行业中,整体涨幅为1.87%。Arcellx, Inc.公司简介:Arcellx Inc是一家临床阶段的生物技术公司,通过开发针对癌症和其他不治之症患者的免疫疗法,重新构思细胞疗法。消息层面,截至21时34分,《Scotiabank:维持Arcellx评级,由跑赢大盘调整至跑赢大盘评级, 目标价由133.00美元调整至93.00美元。》资讯为影响Arcellx, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051221345494f48257&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051221345494f48257&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ACLX"],"gpt_icon":0},{"id":"2534300264","title":"Scotiabank:维持Arcellx(ACLX.US)评级,由跑赢大盘调整至跑赢大盘评级, 目标价由133.00美元调整至93.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2534300264","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534300264?lang=zh_cn&edition=full","pubTime":"2025-05-10 00:26","pubTimestamp":1746808002,"startTime":"0","endTime":"0","summary":"Scotiabank:维持Arcellx(ACLX.US)评级,由跑赢大盘调整至跑赢大盘评级, 目标价由133.00美元调整至93.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/10002650280911.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ACLX"],"gpt_icon":0},{"id":"2534630169","title":"Arcellx(ACLX.US):2025年Q1财报实现营收812.9万美元,前值为3925.6万美元,预期值为1951万美元;每股收益为-1.13美元,前值为-0.14美元,预期值为-0.74美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2534630169","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534630169?lang=zh_cn&edition=full","pubTime":"2025-05-09 04:12","pubTimestamp":1746735140,"startTime":"0","endTime":"0","summary":"Arcellx(ACLX.US):2025年Q1财报实现营收812.9万美元,前值为3925.6万美元,预期值为1951万美元;每股收益为-1.13美元,前值为-0.14美元,预期值为-0.74美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/05/09041250242991.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ACLX"],"gpt_icon":0},{"id":"2533505826","title":"Arcellx, Inc.盘中异动 急速下挫5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533505826","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533505826?lang=zh_cn&edition=full","pubTime":"2025-05-07 00:42","pubTimestamp":1746549743,"startTime":"0","endTime":"0","summary":"北京时间2025年05月07日00时42分,Arcellx, Inc.股票出现波动,股价急速跳水5.01%。Arcellx, Inc.股票所在的生物技术行业中,整体跌幅为5.09%。其相关个股中,Liminatus Pharma Inc C/Wts 30/04/2030 、Celularity Inc C/Wts 16/07/2026 、Sol-Gel Technologies Ltd.涨幅较大,Pasithea Therapeutics Corp.、Galmed Pharmaceuticals Ltd.、Nucana Plc较为活跃,换手率分别为7920.67%、1200.27%、499.39%,振幅较大的相关个股有Pasithea Therapeutics Corp.、Liminatus Pharma Inc C/Wts 30/04/2030 、Polyrizon Ltd.,振幅分别为158.45%、42.31%、40.65%。Arcellx, Inc.公司简介:Arcellx Inc是一家临床阶段的生物技术公司,通过开发针对癌症和其他不治之症患者的免疫疗法,重新构思细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505070042239750e436&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505070042239750e436&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KTTA","BK4139","ACLX"],"gpt_icon":0},{"id":"2529689784","title":"Arcellx, Inc.盘中异动 股价大涨5.99%报66.90美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529689784","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529689784?lang=zh_cn&edition=full","pubTime":"2025-04-23 21:30","pubTimestamp":1745415058,"startTime":"0","endTime":"0","summary":"北京时间2025年04月23日21时30分,Arcellx, Inc.股票出现异动,股价大幅拉升5.99%。截至发稿,该股报66.90美元/股,成交量1887股,换手率0.00%,振幅0.00%。Arcellx, Inc.股票所在的生物技术行业中,整体涨幅为0.00%。Arcellx, Inc.公司简介:Arcellx Inc是一家临床阶段的生物技术公司,通过开发针对癌症和其他不治之症患者的免疫疗法,重新构思细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042321305994dfa6a8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042321305994dfa6a8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCEA","ACLX","BK4139"],"gpt_icon":0},{"id":"2517198430","title":"Arcellx, Inc.2024财年实现净利润-1.07亿美元,同比减少51.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517198430","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517198430?lang=zh_cn&edition=full","pubTime":"2025-03-08 00:00","pubTimestamp":1741363247,"startTime":"0","endTime":"0","summary":"3月8日,Arcellx, Inc.公布财报,公告显示公司2024财年净利润为-1.07亿美元,同比减少51.37%;其中营业收入为1.08亿美元,同比减少1.82%,每股基本收益为-2.00美元。从资产负债表来看,Arcellx, Inc.总负债2.57亿美元,其中短期债务7.54百万美元,资产负债比为2.77,流动比率为4.80。机构评级:截至2025年3月8日,当前有16家机构对Arcellx, Inc.目标价做出预测,其中目标均价为116.12美元,其中最低目标价为104.00美元,最高目标价为134.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308000159a2647f15&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250308000159a2647f15&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACLX"],"gpt_icon":0},{"id":"2517392607","title":"Arcellx, Inc.盘中异动 临近收盘急速上涨5.01%报68.92美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517392607","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517392607?lang=zh_cn&edition=full","pubTime":"2025-03-06 04:34","pubTimestamp":1741206853,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日04时34分,Arcellx, Inc.股票出现波动,股价急速拉升5.01%。截至发稿,该股报68.92美元/股,成交量32.6516万股,换手率0.59%,振幅4.96%。Arcellx, Inc.股票所在的生物技术行业中,整体涨幅为1.94%。Arcellx, Inc.公司简介:Arcellx Inc 是一家临床阶段的生物技术公司,通过开发针对癌症和其他不治之症患者的免疫疗法,重新构想细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306043413989d93c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306043413989d93c2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACLX","BK4139"],"gpt_icon":0},{"id":"2514354397","title":"Arcellx(ACLX.US):2024年Q4财报实现营收1526.6万美元,前值为6314.8万美元,预期值为2547万美元;每股收益为-0.87美元,前值为0.42美元,预期值为-0.48美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514354397","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514354397?lang=zh_cn&edition=full","pubTime":"2025-02-28 07:08","pubTimestamp":1740697716,"startTime":"0","endTime":"0","summary":"Arcellx(ACLX.US):2024年Q4财报实现营收1526.6万美元,前值为6314.8万美元,预期值为2547万美元;每股收益为-0.87美元,前值为0.42美元,预期值为-0.48美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/28070848442544.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ACLX"],"gpt_icon":0},{"id":"1177002654","title":"Arcellx 2024财年GAAP每股收益$(2.00)不及预期$(1.66),销售额$107.936百万低于预期$121.765百万","url":"https://stock-news.laohu8.com/highlight/detail?id=1177002654","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1177002654?lang=zh_cn&edition=full","pubTime":"2025-02-28 05:11","pubTimestamp":1740690666,"startTime":"0","endTime":"0","summary":"Arcellx 2024财年GAAP每股收益$(2.00),不及预期$(1.66);销售额$107.936百万,低于预期$121.765百万。以上内容来自Benzinga Earnings专栏,原文如下:Arcellx FY 2024 GAAP EPS $(2.00) Misses $(1.66) Estimate, Sales $107.936M Miss $121.765M Estimate","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Arcellx 2024财年GAAP每股收益$(2.00)不及预期$(1.66),销售额$107.936百万低于预期$121.765百万","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACLX"],"gpt_icon":0},{"id":"2510133739","title":"Arcellx, Inc.盘中异动 临近午盘股价大跌5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510133739","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510133739?lang=zh_cn&edition=full","pubTime":"2025-02-12 00:52","pubTimestamp":1739292778,"startTime":"0","endTime":"0","summary":"北京时间2025年02月12日00时52分,Arcellx, Inc.股票出现异动,股价急速下挫5.06%。Arcellx, Inc.股票所在的生物技术行业中,整体跌幅为1.46%。其相关个股中,Omega Therapeutics, Inc.、Lipella Pharmaceuticals Inc.、Oramed Pharmaceuticals Inc.涨幅较大,Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.较为活跃,换手率分别为2989.87%、1328.15%、436.81%,振幅较大的相关个股有Omega Therapeutics, Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.,振幅分别为143.33%、59.46%、58.60%。Arcellx, Inc.公司简介:Arcellx Inc 是一家临床阶段的生物技术公司,通过开发针对癌症和其他不治之症患者的免疫疗法,重新构想细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212005259961f603e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212005259961f603e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OMGA","BK4139","OCEA","ACLX","BK4539"],"gpt_icon":0},{"id":"2508141255","title":"Arcellx, Inc.盘中异动 急速下跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508141255","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508141255?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:46","pubTimestamp":1738593999,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时46分,Arcellx, Inc.股票出现异动,股价快速下挫5.03%。Arcellx, Inc.股票所在的生物技术行业中,整体跌幅为0.41%。其相关个股中,Hcw Biologics Inc.、Gh Research Plc、Invivyd, Inc.涨幅较大,Hcw Biologics Inc.、Briacell Therapeutics Corp.、Cyclerion Therapeutics, Inc.较为活跃,换手率分别为414.08%、351.36%、209.86%,振幅较大的相关个股有Hcw Biologics Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Invivyd, Inc.,振幅分别为82.67%、50.76%、35.62%。Arcellx, Inc.公司简介:Arcellx Inc 是一家临床阶段的生物技术公司,通过开发针对癌症和其他不治之症患者的免疫疗法,重新构想细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203224639987971cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203224639987971cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ACLX"],"gpt_icon":0},{"id":"2507672412","title":"Arcellx, Inc.盘中异动 大幅上涨5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507672412","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507672412?lang=zh_cn&edition=full","pubTime":"2025-01-31 03:32","pubTimestamp":1738265569,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日03时32分,Arcellx, Inc.股票出现异动,股价大幅拉升5.09%。Arcellx, Inc.股票所在的生物技术行业中,整体涨幅为0.25%。其相关个股中,Tectonic Therapeutic, Inc.、Alterity Therapeutics Limited、Immatics N V C/Wts 01/07/2025 涨幅较大,Kazia Therapeutics Limited、Silexion Therapeutics Corp、Alterity Therapeutics Limited较为活跃,换手率分别为1793.50%、316.48%、249.15%,振幅较大的相关个股有Cero Therapeutics Holdings, Inc.、Immatics N V C/Wts 01/07/2025 、Alterity Therapeutics Limited,振幅分别为65.98%、64.10%、61.86%。Arcellx, Inc.公司简介:Arcellx Inc 是一家临床阶段的生物技术公司,通过开发针对癌症和其他不治之症患者的免疫疗法,重新构想细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501310332499876d223&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501310332499876d223&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACLX","BK4139"],"gpt_icon":0},{"id":"2503582053","title":"Arcellx, Inc.盘中异动 大幅下跌5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503582053","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503582053?lang=zh_cn&edition=full","pubTime":"2025-01-14 00:16","pubTimestamp":1736784992,"startTime":"0","endTime":"0","summary":"北京时间2025年01月14日00时16分,Arcellx, Inc.股票出现异动,股价快速下挫5.02%。Arcellx, Inc.股票所在的生物技术行业中,整体跌幅为0.96%。其相关个股中,Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.涨幅较大,Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Silexion Therapeutics Corp较为活跃,换手率分别为11486.69%、6274.05%、425.42%,振幅较大的相关个股有Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.,振幅分别为336.09%、216.61%、150.31%。Arcellx, Inc.公司简介:Arcellx Inc 是一家临床阶段的生物技术公司,通过开发针对癌症和其他不治之症患者的免疫疗法,重新构想细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114001633a22058e0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114001633a22058e0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KAPA","ACLX","BK4139","KAIR"],"gpt_icon":0},{"id":"2502862016","title":"Arcellx, Inc.盘中异动 快速下跌5.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2502862016","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502862016?lang=zh_cn&edition=full","pubTime":"2025-01-10 22:40","pubTimestamp":1736520044,"startTime":"0","endTime":"0","summary":"北京时间2025年01月10日22时40分,Arcellx, Inc.股票出现波动,股价快速下跌5.38%。截至发稿,该股报68.37美元/股,成交量4.5242万股,换手率0.08%,振幅2.86%。Arcellx, Inc.股票所在的生物技术行业中,整体跌幅为0.53%。Arcellx, Inc.公司简介:Arcellx Inc 是一家临床阶段的生物技术公司,通过开发针对癌症和其他不治之症患者的免疫疗法,重新构想细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250110224044a21d1008&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250110224044a21d1008&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACLX","BK4139"],"gpt_icon":0},{"id":"2501843775","title":"Arcellx, Inc.盘中异动 早盘股价大跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2501843775","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501843775?lang=zh_cn&edition=full","pubTime":"2025-01-08 22:39","pubTimestamp":1736347168,"startTime":"0","endTime":"0","summary":"北京时间2025年01月08日22时39分,Arcellx, Inc.股票出现异动,股价快速跳水5.07%。截至发稿,该股报73.14美元/股,成交量2.7843万股,换手率0.05%,振幅4.06%。Arcellx, Inc.股票所在的生物技术行业中,整体涨幅为0.03%。Arcellx, Inc.公司简介:Arcellx Inc 是一家临床阶段的生物技术公司,通过开发针对癌症和其他不治之症患者的免疫疗法,重新构想细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108223928a21a555e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250108223928a21a555e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACLX","SANA","BK4139"],"gpt_icon":0},{"id":"2501352261","title":"Arcellx, Inc.盘中异动 下午盘快速下挫5.07%报75.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2501352261","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501352261?lang=zh_cn&edition=full","pubTime":"2025-01-07 03:36","pubTimestamp":1736192206,"startTime":"0","endTime":"0","summary":"北京时间2025年01月07日03时36分,Arcellx, Inc.股票出现异动,股价急速下挫5.07%。截至发稿,该股报75.12美元/股,成交量62.5482万股,换手率1.16%,振幅6.28%。Arcellx, Inc.股票所在的生物技术行业中,整体涨幅为0.43%。Arcellx, Inc.公司简介:Arcellx Inc 是一家临床阶段的生物技术公司,通过开发针对癌症和其他不治之症患者的免疫疗法,重新构想细胞疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010703364695faa7ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010703364695faa7ca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACLX","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.arcellx.com","stockEarnings":[{"period":"1week","weight":0.0246},{"period":"1month","weight":0.1031},{"period":"3month","weight":0.14},{"period":"6month","weight":0.0635},{"period":"1year","weight":0.0725},{"period":"ytd","weight":-0.0781}],"compareEarnings":[{"period":"1week","weight":0.0003},{"period":"1month","weight":0.0357},{"period":"3month","weight":0.1858},{"period":"6month","weight":0.0446},{"period":"1year","weight":0.1051},{"period":"ytd","weight":0.0651}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Arcellx, Inc.于2014年12月在特拉华州注册成立。他们是一家临床阶段的生物技术公司,通过为癌症和其他无法治愈的疾病患者开发创新的免疫疗法来重新构想细胞疗法。他们的新型合成结合支架D-Domain旨在克服传统嵌合抗原受体T细胞的局限性。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.027018},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.048617},{"month":3,"riseRate":0.75,"avgChangeRate":-0.024709},{"month":4,"riseRate":0.25,"avgChangeRate":-0.031462},{"month":5,"riseRate":0.75,"avgChangeRate":0.034373},{"month":6,"riseRate":0.75,"avgChangeRate":0.082898},{"month":7,"riseRate":1,"avgChangeRate":0.105837},{"month":8,"riseRate":0.666667,"avgChangeRate":0.008467},{"month":9,"riseRate":1,"avgChangeRate":0.086834},{"month":10,"riseRate":0.666667,"avgChangeRate":0.080825},{"month":11,"riseRate":0.666667,"avgChangeRate":0.12818},{"month":12,"riseRate":0.666667,"avgChangeRate":0.160328}],"exchange":"NASDAQ","name":"ARCELLX, INC.","nameEN":"ARCELLX, INC."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ARCELLX, INC.(ACLX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供ARCELLX, INC.(ACLX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"ARCELLX, INC.,ACLX,ARCELLX, INC.股票,ARCELLX, INC.股票老虎,ARCELLX, INC.股票老虎国际,ARCELLX, INC.行情,ARCELLX, INC.股票行情,ARCELLX, INC.股价,ARCELLX, INC.股市,ARCELLX, INC.股票价格,ARCELLX, INC.股票交易,ARCELLX, INC.股票购买,ARCELLX, INC.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ARCELLX, INC.(ACLX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供ARCELLX, INC.(ACLX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}